3.01
price down icon2.90%   -0.09
after-market アフターアワーズ: 3.22 0.21 +6.98%
loading

Lipocine Inc (LPCN) 最新ニュース

pulisher
Apr 03, 2025

Lipocine Inc. Reports 2024 Financial Turnaround - TipRanks

Apr 03, 2025
pulisher
Mar 30, 2025

Lipocine (NASDAQ:LPCN) Coverage Initiated by Analysts at StockNews.com - Defense World

Mar 30, 2025
pulisher
Mar 27, 2025

Lipocine’s Phase III trial of LPCN 1154 to begin for postpartum depression - Yahoo

Mar 27, 2025
pulisher
Mar 26, 2025

Lipocine Announces Initiation of Outpatient Phase 3 Postpartum Depression Trial of LPCN 1154 - MarketScreener

Mar 26, 2025
pulisher
Mar 26, 2025

Revolutionary At-Home Postpartum Depression Drug Enters Final Testing Phase - Stock Titan

Mar 26, 2025
pulisher
Mar 22, 2025

StockNews.com Initiates Coverage on Lipocine (NASDAQ:LPCN) - Defense World

Mar 22, 2025
pulisher
Mar 21, 2025

Testosterone, TRAVERSE, And A Label Change 15 Years In The Making - News & Insights

Mar 21, 2025
pulisher
Mar 21, 2025

Lipozem Reviews (2025): Consumer Reports on Lipozem Weight Loss Formula - GlobeNewswire Inc.

Mar 21, 2025
pulisher
Mar 13, 2025

Lipocine Announces Financial Results for the Full Year Ended December 31, 2024 - Quantisnow

Mar 13, 2025
pulisher
Mar 13, 2025

Lipocine Turns Profitable: How $11.2M in Licensing Deals Transformed 2024 Results - StockTitan

Mar 13, 2025
pulisher
Mar 12, 2025

Lipocine to change FDA labeling for testosterone products -March 12, 2025 at 09:59 am EDT - Marketscreener.com

Mar 12, 2025
pulisher
Mar 12, 2025

Lipocine Announces FDA Labeling Changes for Testosterone Products - Citizentribune

Mar 12, 2025
pulisher
Mar 12, 2025

Lipocine announces FDA labeling changes for testosterone products - TipRanks

Mar 12, 2025
pulisher
Mar 12, 2025

FDA Lifts Critical Cardiovascular Warning for Testosterone Treatments: Major Win for Lipocine - StockTitan

Mar 12, 2025
pulisher
Mar 06, 2025

Lipocine (NASDAQ:LPCN) Coverage Initiated at StockNews.com - Defense World

Mar 06, 2025
pulisher
Mar 04, 2025

LPCN stock touches 52-week low at $2.92 amid market challenges By Investing.com - Investing.com South Africa

Mar 04, 2025
pulisher
Mar 04, 2025

LPCN stock touches 52-week low at $2.92 amid market challenges - Investing.com UK

Mar 04, 2025
pulisher
Mar 03, 2025

Lipocine Inc expected to post a loss of 40 cents a shareEarnings Preview - TradingView

Mar 03, 2025
pulisher
Mar 01, 2025

Lipocine to Host Virtual KOL Event on LPCN 2401 for Improved Body Composition in Obesity Management on October 16, 2024 - Marketscreener.com

Mar 01, 2025
pulisher
Feb 27, 2025

Lipocine (LPCN) Expected to Announce Earnings on Thursday - Defense World

Feb 27, 2025
pulisher
Feb 26, 2025

Lipocine (NASDAQ:LPCN) Now Covered by StockNews.com - Defense World

Feb 26, 2025
pulisher
Feb 19, 2025

Lipocine (NASDAQ:LPCN) Now Covered by Analysts at StockNews.com - Armenian Reporter

Feb 19, 2025
pulisher
Feb 11, 2025

Lipocine Updates Corporate Presentation in Recent 8-K Filing - Defense World

Feb 11, 2025
pulisher
Feb 08, 2025

Lipocine (NASDAQ:LPCN) Receives Updated Regulatory Guidance for LPCN 1154 - Defense World

Feb 08, 2025
pulisher
Feb 07, 2025

Lipocine plans phase 3 study for postpartum depression drug - MSN

Feb 07, 2025
pulisher
Feb 06, 2025

Lipocine Inc. Receives Updated Regulatory Guidance on LPCN 1154 -February 06, 2025 at 09:30 am EST - Marketscreener.com

Feb 06, 2025
pulisher
Feb 06, 2025

Lipocine plans phase 3 study for postpartum depression drug By Investing.com - Investing.com South Africa

Feb 06, 2025
pulisher
Feb 06, 2025

Lipocine Receives Updated Regulatory Guidance on LPCN 1154 - The Herald Journal

Feb 06, 2025
pulisher
Feb 02, 2025

Lipocine (NASDAQ:LPCN) Earns Hold Rating from Analysts at StockNews.com - Defense World

Feb 02, 2025
pulisher
Jan 28, 2025

Postpartum Depression Market Expected to rise, 2034 | Pfizer, Sage Therapeutics, Lipocine Inc, Eli Lilly and Company, GSK, Canopie, Talkspace, expected to drive market - Barchart

Jan 28, 2025
pulisher
Jan 20, 2025

Lipocine Updates Corporate Presentation, Files 8-K with SEC - Defense World

Jan 20, 2025
pulisher
Jan 12, 2025

(LPCN) On The My Stocks Page - Stock Traders Daily

Jan 12, 2025
pulisher
Jan 01, 2025

StockNews.com Begins Coverage on Lipocine (NASDAQ:LPCN) - Defense World

Jan 01, 2025
pulisher
Dec 19, 2024

FDA Grants Fast Track Designation to Lipocine (NASDAQ:LPCN) for LPCN 1148 as a Treatment for Sarcopenia in Patients with Decompensated Cirrhosis - Defense World

Dec 19, 2024
pulisher
Dec 17, 2024

Lipocine Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits - Quantisnow

Dec 17, 2024
pulisher
Dec 17, 2024

FDA fast tracks Lipocine's sarcopenia treatment - Investing.com

Dec 17, 2024
pulisher
Dec 17, 2024

FDA Grants Fast Track Designation to Lipocine for LPCN 1148 as a Treatment for Sarcopenia in Patients with Decompensated Cirrhosis - PR Newswire

Dec 17, 2024
pulisher
Dec 17, 2024

FDA Grants Fast Track Designation to LPCN 1148 as Treatment for Sarcopenia - Contract Pharma

Dec 17, 2024
pulisher
Dec 11, 2024

Lipocine to Present at H.C. Wainwright 8th Annual MASH Investor Conference - The Eastern Progress Online

Dec 11, 2024
pulisher
Dec 11, 2024

Lipocine Announces Publication and Discussion of LPCN 1148 Manuscript at The Liver Meeting 2024 Editor's Cut Session - The Eastern Progress Online

Dec 11, 2024
pulisher
Dec 11, 2024

Where are the Opportunities in (LPCN) - Stock Traders Daily

Dec 11, 2024
$60.26
price down icon 10.70%
$69.18
price down icon 5.66%
$17.36
price down icon 8.20%
$31.11
price down icon 2.14%
$88.05
price down icon 4.30%
biotechnology ONC
$238.51
price down icon 9.76%
大文字化:     |  ボリューム (24 時間):